Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial

Short-term studies have suggested that the use of initial combination therapy for the control of blood pressure improves early effectiveness. We tested whether a combination of aliskiren and amlodipine is superior to each monotherapy in early control of blood pressure without excess of adverse event...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The Lancet (British edition) Ročník 377; číslo 9762; s. 312 - 320
Hlavní autoři:	Brown, Morris J, McInnes, Gordon T, Papst, Cheraz Cherif, Zhang, Jack, MacDonald, Thomas M
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Kidlington Elsevier Ltd 22.01.2011 Elsevier Elsevier Limited
Témata:	Amides - therapeutic use Amlodipine - therapeutic use Antihypertensive Agents - therapeutic use Arterial hypertension. Arterial hypotension Biological and medical sciences Blood and lymphatic vessels Blood pressure Calcium Channel Blockers - therapeutic use Calcium channels Cardiology. Vascular system Clinical trials Diastole - drug effects Double-Blind Method Drug therapy Drug Therapy, Combination Edema Female Fumarates - therapeutic use General aspects Humans Hypertension Hypertension - drug therapy Hypotension Internal Medicine Male Medical sciences Middle Aged Mortality patients Systole - drug effects systolic blood pressure therapeutics Antianginal agent Hypertension Enzyme Calcium antagonist Enzyme inhibitor Aliskiren Check Non peptide compound Cardiovascular disease Medicine Peptidases Randomization Renin Treatment Surveillance Amlodipine Hydrolases Antihypertensive agent Clinical trial Strategy Aspartic endopeptidases Dihydropyridine derivatives
ISSN:	0140-6736, 1474-547X, 1474-547X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!